These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry.
    Author: Li W, Han J, Li Z, Li X, Zhou S, Liu C.
    Journal: J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb 01; 862(1-2):51-7. PubMed ID: 18054294.
    Abstract:
    A novel preparative HPLC method separating silybin has been developed to meet the need for both silybin A and silybin B standard. After the preparation of silybin A and silybin B standard, a simple, sensitive, selective and reproducible liquid chromatography-tandem mass spectrometry (LC-MS-MS) method with negative electrospray ionization (ESI) was developed for the quantification of silybin A and silybin B in human plasma. Following rapid sample preparation, silybin A, silybin B and naringin (internal standard, ISTD) were separated on a Zorbax Eclipse XDB-C18 column, using methanol-water containing 0.1% formic acid (48:52, v/v) as the mobile phase. The mass spectrometer was operated in selected reaction monitoring (SRM) mode using the transition m/z 481.1-->300.9 for both silybin A and silybin B and m/z 579.2-->271.1 for naringin, respectively. Linear calibration curves were obtained in the concentration range of 2-5000ng/ml with a lower limit of quantitation (LLOQ) of 2ng/ml for both silybin A and silybin B, respectively. The intra- and inter-day precision values were below 7.5% and accuracy was within +/-4.9% at all three quality control (QC) levels, for both silybin A and silybin B, respectively. This method was successfully applied to the stereospecific analysis of silybin in plasma samples from a pharmacokinetic study of silybin A and silybin B in 22 healthy male Chinese volunteers after a single oral dose of silybin-phosphatidylcholine complex (equivalent to 280mg silybin, including 133mg silybin A and 147mg silybin B).
    [Abstract] [Full Text] [Related] [New Search]